These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26150452)

  • 41. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit.
    Peta M; Carretto E; Barbarini D; Zamperoni A; Carnevale L; Perversi L; Pagani M; Bonora MG; Fontana R; Marone P; Langer M
    Clin Microbiol Infect; 2006 Feb; 12(2):163-9. PubMed ID: 16441455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.
    McDonald LC; Kuehnert MJ; Tenover FC; Jarvis WR
    Emerg Infect Dis; 1997; 3(3):311-7. PubMed ID: 9284375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper .
    Cohen AL; Calfee D; Fridkin SK; Huang SS; Jernigan JA; Lautenbach E; Oriola S; Ramsey KM; Salgado CD; Weinstein RA;
    Infect Control Hosp Epidemiol; 2008 Oct; 29(10):901-13. PubMed ID: 18808340
    [No Abstract]   [Full Text] [Related]  

  • 44. [Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance].
    Klare I; Witte W; Wendt C; Werner G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1387-400. PubMed ID: 23114437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada.
    ;
    Can Commun Dis Rep; 1997 Dec; 23 Suppl 8():i-iv, 1-16, i-iv, 1-19. PubMed ID: 11195274
    [No Abstract]   [Full Text] [Related]  

  • 46. Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.
    Suleyman G; Zervos MJ
    Expert Opin Drug Saf; 2016; 15(2):153-67. PubMed ID: 26629598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging resistance in Enterococcus spp.
    Heath CH; Blackmore TK; Gordon DL
    Med J Aust; 1996 Jan; 164(2):116-20. PubMed ID: 8569563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vancomycin-resistant enterococci.
    Commun Dis Rep CDR Wkly; 1992 Jul; 2(27):121. PubMed ID: 1285233
    [No Abstract]   [Full Text] [Related]  

  • 49. Enterococcal infections & antimicrobial resistance.
    Sood S; Malhotra M; Das BK; Kapil A
    Indian J Med Res; 2008 Aug; 128(2):111-21. PubMed ID: 19001673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibiotic resistant enterococci-tales of a drug resistance gene trafficker.
    Werner G; Coque TM; Franz CM; Grohmann E; Hegstad K; Jensen L; van Schaik W; Weaver K
    Int J Med Microbiol; 2013 Aug; 303(6-7):360-79. PubMed ID: 23602510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Aminoglycoside-resistant enterococci a new bacterial hazard].
    Melhus A
    Lakartidningen; 1999 Apr; 96(14):1694-5. PubMed ID: 10222683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
    Ntokou E; Stathopoulos C; Kristo I; Dimitroulia E; Labrou M; Vasdeki A; Makris D; Zakynthinos E; Tsakris A; Pournaras S
    J Antimicrob Chemother; 2012 Aug; 67(8):1819-23. PubMed ID: 22532462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vancomycin-resistant enterococcal urinary tract infections.
    Heintz BH; Halilovic J; Christensen CL
    Pharmacotherapy; 2010 Nov; 30(11):1136-49. PubMed ID: 20973687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence, species distribution and antimicrobial resistance of enterococci isolated from dogs and cats in the United States.
    Jackson CR; Fedorka-Cray PJ; Davis JA; Barrett JB; Frye JG
    J Appl Microbiol; 2009 Oct; 107(4):1269-78. PubMed ID: 19486402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of a large cluster of vancomycin-resistant enterococci in an Australian hospital.
    Cooper E; Paull A; O'Reilly M
    Infect Control Hosp Epidemiol; 2002 Mar; 23(3):151-3. PubMed ID: 11918122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Debate-guidelines for control of glycopeptide-resistant enterococci (GRE) have not yet worked.
    McGowan JE
    J Hosp Infect; 2004 Aug; 57(4):281-4. PubMed ID: 15320355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of antibiotic resistance in enterococci.
    Miller WR; Munita JM; Arias CA
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1221-36. PubMed ID: 25199988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rising incidence of Enterococcus species in microbiological specimens from orthopedic patients correlates to increased use of cefuroxime: a study concentrating on tissue samples.
    Siesing PC; Alva-Jørgensen JP; Brodersen J; Arpi M; Jensen PE
    Acta Orthop; 2013 Jun; 84(3):319-22. PubMed ID: 23594224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ampicillin-resistant Enterococcus raffinosus in an acute-care hospital: case-control study and antimicrobial susceptibilities.
    Chirurgi VA; Oster SE; Goldberg AA; Zervos MJ; McCabe RE
    J Clin Microbiol; 1991 Nov; 29(11):2663-5. PubMed ID: 1774284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nosocomial enterococcal infection in neonates.
    Bilikova E; Koprnova J; Hafed BM; Svetlansky I; Chovancova D; Drobna M; Huttova M; Krcmery V
    Int J Infect Dis; 2004 Mar; 8(2):127-9. PubMed ID: 14732331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.